Several studies have validated the presence of cholinergic insufficiency in individuals diagnosed with AD, demonstrating notable deficiencies in choline acetyltransferase (ChAT), the enzyme responsible for the synthesis of acetylcholine (ACh), as well as diminished choline uptake, reduced ACh secretion, and depletion of cholinergic neurons. Here, CHAT is linked to Alzheimer disease.